MTRY Stock Ownership Activity

MONTEREY BIO ACQUISITION COR 13F holders

No value investing guru has made any change to the MONTEREY BIO ACQUISITION COR (MTRY) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying MTRY now?

According to the latest SEC filing(s) MONTEREY BIO ACQUISITION COR (MTRY) has not been purchased by any super investor.

To see more about who is investing in MONTEREY BIO ACQUISITION COR (MTRY), please go to the MTRY ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2022 Q4 (1 result)
Howard Marks
Oaktree Capital Management
-100.00%
-150,000
-0.02%
0.00%
Current price: $11.14 4.70% Reported price*: $10.64
2021 Q4 (1 result)
Howard Marks
Oaktree Capital Management
buy
+105,750
+0.02%
0.01%
Current price: $11.14 12.83% Reported price*: $9.87
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.